000424

Schumock // Pharmacotherapy, 1998, 18(6), 1284-1289. 180. Tissot, E. Medication Errors at the Administration Stage in an Intensive Care Unit / E. Tissot [et al.] //Intensive Care. Med., 1999, 25(4), 353-359. 181. Selecting Indicators for Patient Safety at the Health Systems Level in OECD Countries. DELSA/ELSA/WD/HTP(2004)18.(техническийдокументздоровья OECD DELSA/ELSA/WD/HTP (2004) www.oecd.org/els/health/technicalpapers) 182. Spontaneous Reporting Systems Outside the US / B.E. Wiholm [et al.] // Pharmacoepidemiology, Third Edition by B.L.Strom, 2000, p.175- 192. 183. Suh, D.C. Clinical and economic impact of adverse drug reactions in hospitalized patients / D.C. Suh, B.S. Woodall, S.K. Shin // Ann Pharmacother, 2000, 34(12), 1373-1379. 184. Systems analysis of adverse drug events / L. Leape [et al.] // JAMA, 1995, 274, 35-43. 185. Hochohaus, G. Evolution of prarmacokinetics and pharmacokinetics / G. Hochohaus, J.S.Barrett //J. Clin. Pharmacol., 2000. - N 9. -p.908-917. 186. The costs of adverse drug events in hospitalized patients / D.W. Bates [et al.] // JAMA, 1997, 277, 307-311. 187. The Institute for Healthcare Improvement, The Quest for Error- Proof Medicine, Drug Benefit, 1997, 9(6), 18-29. 188. Van Maaren, P.J.M. Dutch druds in developing countries. Styx Publication, Nothern Centre for Health Care, University of Gronibgen, 1994. 189. Vere, D.W. Drug adverse reactions as masqueraders / D.W. Vere // Adverse Drug Reaction Bull. - 1976. - 60: 208-211. 190. Vincen, J. D. Radiometry - fundamentals of infrared detector operation and testing / J. D. Vincen. - New York: Wiley, 1990. - Ch. 3. - 197 - 197